Original Research

Published on 10 Jun 2022

Perfusion Imaging of Fatigue and Time-on-Task Effects in Patients With Parkinson’s Disease

in Parkinson’s Disease and Aging-related Movement Disorders

Wanting Liu
Jianghong Liu
Rupal Bhavsar
Tianxin Mao
Eugenia Mamikonyan
David Raizen
John A. Detre
Daniel Weintraub
Hengyi Rao

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2022.901203

2,689 views
4 citations

Mini Review

Published on 08 Jun 2022

PINK1/Parkin Pathway Activation for Mitochondrial Quality Control – Which Is the Best Molecular Target for Therapy?

in Parkinson’s Disease and Aging-related Movement Disorders

Laura F. Silvian

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2022.890823

8,182 views
23 citations

Original Research

Published on 03 Jun 2022

Electroencephalography Microstate Alterations in Otogenic Vertigo: A Potential Disease Marker

in Parkinson’s Disease and Aging-related Movement Disorders

Yi-Ni Li
Wen Lu
Jie Li
Ming-Xian Li
Jia Fang
Tao Xu
Ti-Fei Yuan
Di Qian
Hai-Bo Shi
Shan-Kai Yin

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2022.914920

2,975 views
6 citations

Original Research

Published on 02 Jun 2022

Uric Acid Enhances Neurogenesis in a Parkinsonian Model by Remodeling Mitochondria

in Parkinson’s Disease and Aging-related Movement Disorders

Ji Eun Lee
Yu Jin Shin
Yi Seul Kim
Ha Na Kim
Dong Yeol Kim
Seok Jong Chung
Han Soo Yoo
Jin Young Shin
Phil Hyu Lee

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2022.851711

3,865 views
7 citations

Original Research

Published on 02 Jun 2022

Growth Differentiation Factor 15 Protects SH-SY5Y Cells From Rotenone-Induced Toxicity by Suppressing Mitochondrial Apoptosis

in Parkinson’s Disease and Aging-related Movement Disorders

Peizheng Li
Hongbo Lv
Bohan Zhang
Ruonan Duan
Xiufang Zhang
Pengfei Lin
Chengyuan Song
Yiming Liu

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2022.869558

7,625 views
18 citations

Systematic Review

Published on 26 May 2022

Alpha-Synuclein Strain Variability in Body-First and Brain-First Synucleinopathies

in Parkinson’s Disease and Aging-related Movement Disorders

Mie Kristine Just
Hjalte Gram
Vasileios Theologidis
Poul Henning Jensen
K. Peter R. Nilsson
Mikael Lindgren
Karoline Knudsen
Per Borghammer
Nathalie Van Den Berge

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2022.907293

7,956 views
19 citations

Original Research

Published on 23 May 2022

Functional Interactions Between the Parafascicular Thalamic Nucleus and Motor Cortex Are Altered in Hemiparkinsonian Rat

in Parkinson’s Disease and Aging-related Movement Disorders

Min Li
Xiao Zhang
Qin He
Dadian Chen
Feiyu Chen
Xiaojun Wang
Shuang Sun
Yue Sun
Yuchuan Li
Zhiwei Zhu

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2022.800159

2,561 views
1 citation

Original Research

Published on 23 May 2022

Graph Theoretical Analysis of Structural Covariance Reveals the Relevance of Visuospatial and Attentional Areas in Essential Tremor Recovery After Stereotactic Radiosurgical Thalamotomy

in Parkinson’s Disease and Aging-related Movement Disorders

Thomas A. W. Bolton
Dimitri Van De Ville
Jean Régis
Tatiana Witjas
Nadine Girard
Marc Levivier
Constantin Tuleasca

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2022.873605

2,318 views
8 citations

Original Research

Published on 20 May 2022

Receptor-Dependent Endocytosis Mediates α-Synuclein Oligomer Transport Into Red Blood Cells

in Parkinson’s Disease and Aging-related Movement Disorders

Wei Li
Junya Hu
Xin Li
Zhe Lu
Xuying Li
Chaodong Wang
Shun Yu

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2022.899892

2,596 views
5 citations

Systematic Review

Published on 18 May 2022

Pathological Role of Natural Killer Cells in Parkinson's Disease: A Systematic Review

in Parkinson’s Disease and Aging-related Movement Disorders

Le Zhang
Yingshuang Zhang
Dongsheng Fan

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2022.890816

2,895 views
4 citations

Original Research

Published on 17 May 2022

The Gut Microbiome in Parkinson’s Disease: A Longitudinal Study of the Impacts on Disease Progression and the Use of Device-Assisted Therapies

in Parkinson’s Disease and Aging-related Movement Disorders

Michal Lubomski
Xiangnan Xu
Andrew J. Holmes
Samuel Muller
Jean Y. H. Yang
Ryan L. Davis
Carolyn M. Sue

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2022.875261

8,697 views
27 citations

Opinion

Published on 17 May 2022

A Roadmap for Future Parkinson's Pharmacogenomics in Asia

in Parkinson’s Disease and Aging-related Movement Disorders

Muhammad Akbar
Gita Vita Soraya
Zulvikar Syambani Ulhaq
Andi Kurnia Bintang

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2022.896371

2,027 views

Original Research

Published on 16 May 2022

Characterization of Mild and Moderate Dysarthria in Parkinson’s Disease: Behavioral Measures and Neural Correlates

in Parkinson’s Disease and Aging-related Movement Disorders

Hanna Steurer
Ellika Schalling
Erika Franzén
Franziska Albrecht

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2022.870998

4,649 views
10 citations

Study Protocol

Published on 13 May 2022

Parkinson’s Disease Medication Adherence Scale: Conceptualization, Scale Development, and Clinimetric Testing Plan

in Parkinson’s Disease and Aging-related Movement Disorders

Michelle H. S. Tosin
Christopher G. Goetz
Dharah P. C. F. Bispo
Henrique B. Ferraz
Marco Antonio A. Leite
Deborah A. Hall
Glenn T. Stebbins
Beatriz Guitton R. B. Oliveira

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2022.900029

2,676 views
1 citation

Review

Published on 13 May 2022

Application of Neurotoxin-Induced Animal Models in the Study of Parkinson’s Disease-Related Depression: Profile and Proposal

in Parkinson’s Disease and Aging-related Movement Disorders

Ya-Kui Mou
Li-Na Guan
Xiao-Yan Yao
Jia-Hui Wang
Xiao-Yu Song
Yong-Qiang Ji
Chao Ren
Shi-Zhuang Wei

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2022.890512

3,584 views
8 citations

Original Research

Published on 12 May 2022

Lewy Body-Associated Proteins A-Synuclein (a-syn) as a Plasma-Based Biomarker for Parkinson’s Disease

in Parkinson’s Disease and Aging-related Movement Disorders

Xuemiao Zhao
Haijun He
Xi Xiong
Qianqian Ye
Feifei Feng
Shuoting Zhou
Weian Chen
Kai Xia
Shuangjie Qian
Yunjun Yang

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2022.869797

4,310 views
10 citations

Navigation group

Articles

Perfusion Imaging of Fatigue and Time-on-Task Effects in Patients With Parkinson’s Disease

PINK1/Parkin Pathway Activation for Mitochondrial Quality Control – Which Is the Best Molecular Target for Therapy?

Electroencephalography Microstate Alterations in Otogenic Vertigo: A Potential Disease Marker

Uric Acid Enhances Neurogenesis in a Parkinsonian Model by Remodeling Mitochondria

Growth Differentiation Factor 15 Protects SH-SY5Y Cells From Rotenone-Induced Toxicity by Suppressing Mitochondrial Apoptosis

Alpha-Synuclein Strain Variability in Body-First and Brain-First Synucleinopathies

Functional Interactions Between the Parafascicular Thalamic Nucleus and Motor Cortex Are Altered in Hemiparkinsonian Rat

Graph Theoretical Analysis of Structural Covariance Reveals the Relevance of Visuospatial and Attentional Areas in Essential Tremor Recovery After Stereotactic Radiosurgical Thalamotomy

Receptor-Dependent Endocytosis Mediates α-Synuclein Oligomer Transport Into Red Blood Cells

Pathological Role of Natural Killer Cells in Parkinson's Disease: A Systematic Review

The Gut Microbiome in Parkinson’s Disease: A Longitudinal Study of the Impacts on Disease Progression and the Use of Device-Assisted Therapies

A Roadmap for Future Parkinson's Pharmacogenomics in Asia

Characterization of Mild and Moderate Dysarthria in Parkinson’s Disease: Behavioral Measures and Neural Correlates

Parkinson’s Disease Medication Adherence Scale: Conceptualization, Scale Development, and Clinimetric Testing Plan

Application of Neurotoxin-Induced Animal Models in the Study of Parkinson’s Disease-Related Depression: Profile and Proposal

Lewy Body-Associated Proteins A-Synuclein (a-syn) as a Plasma-Based Biomarker for Parkinson’s Disease